The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
Clinical Application of Radiolabeled RGD Peptides for PET Imaging of Integrin αvβ3
Open accessAbstract
Molecular imaging for non-invasive assessment of angiogenesisis is of great interest for clinicians because of the wide-spread application of anti-angiogenic cancer therapeutics. Besides, many other interventions that involve the change of blood vessel/tumor microenvironment would also benefit from such imaging strategies. Of the imaging techniques that target angiogenesis, radiolabeled Arg-Gly-Asp (RGD) peptides have been a major focus because of their high affinity and selectivity for integrin αvβ3--one of the most extensively examined target of angiogenesis. Since the level of integrin αvβ3 expression has been established as a surrogate marker of angiogenic activity, imaging αvβ3 expression can potentially be used as an early indicator of effectiveness of antiangiogenic therapy at the molecular level. In this review, we summarize RGD-based PET tracers that have already been used in clinical trials and intercompared them in terms of radiosynthesis, dosimetry, pharmacokinetics and clinical applications. A perspective of their future use in the clinic is also provided.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Inflammation in atherosclerosis
Libby, P. (2002) · Nature · doi:10.1038/nature01323 · Cited by 8,315
Angiogenesis in cancer, vascular, rheumatoid and other disease
Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0195-27 · Cited by 7,627
Recommendations of the International Commission on Radiological Protection
(1961) · Postgraduate Medical Journal · doi:10.1136/pgmj.37.425.168-b · Cited by 5,862
Angiogenesis in health and disease
Carmeliet, P. (2003) · Nature Medicine · doi:10.1038/nm0603-653 · Cited by 4,276
The 2007 recommendations of the International Commission on Radiological Protection
Valentin, J. (2007) · Elsevier eBooks · Cited by 4,105
Giancotti, F. G., & Ruoslahti, E. (1999) · Science · doi:10.1126/science.285.5430.1028 · Cited by 3,869
Inflammation in Atherosclerosis
Libby, P. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.179705 · Cited by 3,736
Molecular imaging in living subjects: seeing fundamental biological processes in a new light
Massoud, T. F., & Gambhir, S. S. (2003) · Genes & Development · doi:10.1101/gad.1047403 · Cited by 2,216
Preface, Executive Summary and Glossary
(2007) · Annals of the ICRP · doi:10.1016/j.icrp.2007.10.003 · Cited by 2,106
Recommendations of the International Commission on Radiological Protection, ICRP Publication 26
Icrp (1977) · Annals of the ICRP · Cited by 1,780
Virmani, R., Kolodgie, F. D., Burke, A. P., Finn, A. V., Gold, H. K., Tulenko, T. N., Wrenn, S. P., & Narula, J. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000178991.71605.18 · Cited by 1,331
Takada, Y., Ye, X., & Simon, S. (2007) · Genome Biology · doi:10.1186/gb-2007-8-5-215 · Cited by 1,205
Integrins in angiogenesis and lymphangiogenesis
Avraamides, C. J., Garmy-Susini, B., & Varner, J. A. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2353 · Cited by 1,050
Atherosclerosis — An Inflammatory Disease
(1999) · New England Journal of Medicine · doi:10.1056/nejm199906173402418 · Cited by 870
Suzuki, J. (1986) · Cited by 560
Whole-Body PET/CT Scanning: Estimation of Radiation Dose and Cancer Risk
Huang, B., Law, M. W.-M., & Khong, P.-L. (2009) · Radiology · doi:10.1148/radiol.2511081300 · Cited by 522
Haubner, R., Weber, W. A., Beer, A. J., Vabuliene, E., Reim, D., Sarbia, M., Becker, K.-F., Goebel, M., Hein, R., Wester, H.-J., et al. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020070 · Cited by 489
Radiation exposure of patients undergoing whole-body dual-modality 18F-FDG PET/CT examinations.
Brix, G., Lechel, U., Glatting, G., Ziegler, S. I., Münzing, W., Müller, S. P., & Beyer, T. (2005) · PubMed · Cited by 458
Schiller, N. K., Boisvert, W. A., & Curtiss, L. K. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000024082.46387.38 · Cited by 456
Role of Angiogenesis in Cardiovascular Disease: A Critical Appraisal
Khurana, R., Simons, M., Martin, J. F., & Zachary, I. C. (2005) · Circulation · doi:10.1161/circulationaha.105.535294 · Cited by 451
A Novel Method of 18F Radiolabeling for PET
McBride, W. J., Sharkey, R. M., Karacay, H., D'Souza, C. A., Rossi, E. A., Laverman, P., Chang, C.-H., Boerman, O. C., & Goldenberg, D. M. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.060418 · Cited by 418
Rolli, M., Fransvea, E., Pilch, J., Saven, A., & Felding-Habermann, B. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1633689100 · Cited by 332
Beer, A. J., Haubner, R., Sarbia, M., Goebel, M., Luderschmidt, S., Grosu, A. L., Schnell, O., Niemeyer, M., Kessler, H., Wester, H.-J., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0266 · Cited by 330
Wu, Y., Zhang, X., Xiong, Z., Cheng, Z., Fisher, D. R., Liu, S., Gambhir, S. S., & Chen, X. S. (2005) · PubMed · Cited by 325
Self-citationQuantitative PET imaging of tumor integrin alphavbeta3 expression with 18F-FRGD2.
Zhang, X., Xiong, Z., Wu, Y., Cai, W., Tseng, J. R., Gambhir, S. S., & Chen, X. S. (2006) · PubMed · Cited by 282
Self-citationKenny, L. M., Coombes, R. C., Oulie, I., Contractor, K. B., Miller, M., Spinks, T. J., McParland, B., Cohen, P. S., Hui, A.-M., Palmieri, C., et al. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.049452 · Cited by 280
Thumshirn, G., Hersel, U., Goodman, S. L., & Kessler, H. (2003) · Chemistry – A European Journal · doi:10.1002/chem.200204304 · Cited by 269
Zitzmann, S., Ehemann, V., & Schwab, M. (2002) · PubMed · Cited by 265
Beer, A. J., Haubner, R., Goebel, M., Luderschmidt, S., Spilker, M. E., Wester, H., Weber, W., & Schwaiger, M. (2005) · PubMed · Cited by 258
Fukui, M., Kono, S., Sueishi, K., & Ikezaki, K. (2000) · Neuropathology · doi:10.1046/j.1440-1789.2000.00300.x · Cited by 257
Li, Z.-B., Cai, W., Cao, Q., Chen, K., Wu, Z., He, L., & Chen, X. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.039859 · Cited by 251
Self-citationNanoparticle Imaging of Integrins on Tumor Cells
Montet, X., Montet-Abou, K., Reynolds, F., Weissleder, R., & Josephson, L. (2006) · Neoplasia · doi:10.1593/neo.05769 · Cited by 251
Integrin alpha(v)beta3 promotes M21 melanoma growth in human skin by regulating tumor cell survival.
Petitclerc, É., Strömblad, S., Schalscha, T. V., Mitjans, F., Piulats, J., Montgomery, A. M. P., Cheresh, D. A., & Brooks, P. C. (1999) · PubMed · Cited by 237
Radiolabelled RGD peptides for imaging and therapy
Gaertner, F. C., Kessler, H., Wester, H.-J., Schwaiger, M., & Beer, A. J. (2012) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-011-2028-1 · Cited by 227
Poethko, T., Schottelius, M., Thumshirn, G., Hersel, U., Herz, M., Henriksen, G., Kessler, H., Schwaiger, M., & Wester, H. (2004) · PubMed · Cited by 227
α v β 3 Integrin Expression in Normal and Atherosclerotic Artery
Hoshiga, M., Alpers, C. E., Smith, L. L., Giachelli, C. M., & Schwartz, S. M. (1995) · Circulation Research · doi:10.1161/01.res.77.6.1129 · Cited by 225
Beer, A. J., Grosu, A.-L., Carlsen, J., Kolk, A., Sarbia, M., Stangier, I., Watzlowik, P., Wester, H.-J., Haubner, R., & Schwaiger, M. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0528 · Cited by 217
Tumor αvβ3 Integrin Is a Therapeutic Target for Breast Cancer Bone Metastases
Zhao, Y., Bachelier, R., Treilleux, I., Pujuguet, P., Peyruchaud, O., Baron, R., Clément-Lacroix, P., & Clézardin, P. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4499 · Cited by 210
Burke, P. A., DeNardo, S. J., Miers, L. A., Lamborn, K. R., Matzku, S., & DeNardo, G. L. (2002) · PubMed · Cited by 209
Improved 18F Labeling of Peptides with a Fluoride-Aluminum-Chelate Complex
McBride, W. J., D’Souza, C. A., Sharkey, R. M., Karacay, H., Rossi, E. A., Chang, C.-H., & Goldenberg, D. M. (2010) · Bioconjugate Chemistry · doi:10.1021/bc100137x · Cited by 200
Schnell, O., Krebs, B., Carlsen, J., Miederer, I., Goetz, C., Goldbrunner, R. H., Wester, H.-J., Haubner, R., Pöpperl, G., Holtmannspötter, M., et al. (2009) · Neuro-Oncology · doi:10.1215/15228517-2009-024 · Cited by 199
Jeong, J. M., Hong, M. K., Chang, Y. S., Lee, Y., Kim, Y. J., Cheon, G. J., Lee, D. S., Chung, J., & Lee, M. C. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.047423 · Cited by 197
68Ga-labeled multimeric RGD peptides for microPET imaging of integrin αvβ3 expression
Li, Z.-B., Chen, K., & Chen, X. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0692-y · Cited by 190
Self-citationWhy Integrin as a Primary Target for Imaging and Therapy
Niu, G., & Chen, X. (2011) · Theranostics · doi:10.7150/thno/v01p0030 · Cited by 179
Self-citationImaging of Integrins as Biomarkers for Tumor Angiogenesis
Cai, W., Niu, G., & Chen, X. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208786404308 · Cited by 178
Self-citationBeer, A. J., Niemeyer, M., Carlsen, J., Sarbia, M., Nährig, J., Watzlowik, P., Wester, H.-J., Harbeck, N., & Schwaiger, M. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.045526 · Cited by 174
Wan, W., Guo, N., Pan, D., Yu, C., Weng, Y., Luo, S., Ding, H., Xu, Y., Wang, L., Lang, L., et al. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.113563 · Cited by 171
Self-citationBeer, A. J., Lorenzen, S., Metz, S., Herrmann, K., Watzlowik, P., Wester, H.-J., Peschel, C., Lordick, F., & Schwaiger, M. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.045864 · Cited by 167
Micro-PET Imaging of αvβ3-Integrin Expression with 18F-Labeled Dimeric RGD Peptide
Chen, X., Tohme, M., Park, R., Hou, Y., Bading, J. R., & Conti, P. S. (2004) · Molecular Imaging · doi:10.1162/1535350041464892 · Cited by 159
Self-citationPET/CT Imaging of Integrin αvβ3 Expression in Human Carotid Atherosclerosis
Beer, A. J., Pelisek, J., Heider, P., Saraste, A., Reeps, C., Metz, S., Seidl, S., Kessler, H., Wester, H.-J., Eckstein, H. H., et al. (2014) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2013.12.003 · Cited by 158
Integrin Targeting for Tumor Optical Imaging
Ye, Y., & Chen, X. S. (2011) · Theranostics · doi:10.7150/thno/v01p0102 · Cited by 154
Self-citationRadiolabeled Cyclic RGD Peptides as Radiotracers for Imaging Tumors and Thrombosis by SPECT
Zhou, Y., Chakraborty, S., & Liu, S. (2011) · Theranostics · doi:10.7150/thno/v01p0058 · Cited by 149
Lang, L., Li, W., Guo, N., Ma, Y., Zhu, L., Kiesewetter, D. O., Shen, B., Niu, G., & Chen, X. S. (2011) · Bioconjugate Chemistry · doi:10.1021/bc200197h · Cited by 148
Self-citationBeer, A. J., Haubner, R., Wolf, I., Goebel, M., Luderschmidt, S., Niemeyer, M., Grosu, A., Martínez, M.-J., Wester, H. J., Weber, W., et al. (2006) · PubMed · Cited by 144
18F-Labeled Galacto and PEGylated RGD Dimers for PET Imaging of αvβ3 Integrin Expression
Liu, S., Liu, Z., Chen, K., Yan, Y., Watzlowik, P., Wester, H., Chin, F. T., & Chen, X. S. (2009) · Molecular Imaging and Biology · doi:10.1007/s11307-009-0284-2 · Cited by 133
Self-citationMittra, E., Goris, M. L., Iagaru, A. H., Kardan, A., Burton, L., Berganos, R. A., Chang, E., Liu, S., Shen, B., Chin, F. T., et al. (2011) · Radiology · doi:10.1148/radiol.11101139 · Cited by 130
Self-citationBattle, M. R., Goggi, J., Allen, L., Barnett, J., & Morrison, M. S. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.077479 · Cited by 121
Liu, Z., Liu, S., Wang, F., Liu, S., & Chen, X. S. (2009) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-009-1112-2 · Cited by 118
Self-citationPositron emission tomography tracers for imaging angiogenesis
Haubner, R., Beer, A. J., Wang, H., & Chen, X. S. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1503-4 · Cited by 112
Self-citationDoss, M., Kolb, H. C., Zhang, J., Bélanger, M.-J., Stubbs, J. B., Stabin, M. G., Hostetler, E. D., Alpaugh, R. K., von Mehren, M., Walsh, J. C., et al. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.088955 · Cited by 100
Makowski, M. R., Ebersberger, U., Nekolla, S. G., & Schwaiger, M. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn129 · Cited by 96
Yoon, H., Kang, K. W., Chun, I. K., Cho, N., Im, S., Jeong-Yu, S., Lee, S., Jung, K. C., Lee, Y., Jeong, J. M., et al. (2014) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-014-2744-4 · Cited by 83
68Ga-NOTA-PRGD2 PET/CT for Integrin Imaging in Patients with Lung Cancer
Zheng, K., Liang, N., Zhang, J., Lang, L., Zhang, W., Li, S., Zhao, J., Niu, G., Li, F., Zhu, Z., et al. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.160648 · Cited by 81
Self-citationApplication of 68Ga-PRGD2 PET/CT for αvβ3-integrin Imaging of Myocardial Infarction and Stroke
Sun, Y., Zeng, Y., Zhu, Y., et al. (2014) · Theranostics · doi:10.7150/thno.8809 · Cited by 63
Guo, N., Lang, L., Li, W., Kiesewetter, D. O., Gao, H., Niu, G., Xie, Q., & Chen, X. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037506 · Cited by 60
Self-citationImaging Tumor Angiogenesis: The Road to Clinical Utility
Iagaru, A. H., & Gambhir, S. S. (2013) · American Journal of Roentgenology · doi:10.2214/ajr.12.8568 · Cited by 57
Kim, J. H., Lee, J. S., Kang, K. W., Lee, H., Han, S., Kim, T., Lee, Y., Jeong, J. M., & Lee, D. S. (2011) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2011.1061 · Cited by 55
Verjans, J. W. H., Wolters, S. L., Laufer, W., Schellings, M. W. M., Lax, M., Løvhaug, D., Boersma, H. H., Kemerink, G. J., Schalla, S. M., Gordon, P., et al. (2010) · Journal of Nuclear Cardiology · doi:10.1007/s12350-010-9268-5 · Cited by 51
Wu, C., Yue, X., Lang, L., Kiesewetter, D. O., Li, F., Zhu, Z., Niu, G., & Chen, X. S. (2014) · Theranostics · doi:10.7150/thno.8159 · Cited by 49
Self-citationMena, E., Owenius, R., Türkbey, B., Sherry, R. M., Bratslavsky, G., Macholl, S., Miller, M. P., Somer, E. J., Lindenberg, L., Adler, S., et al. (2014) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-014-2791-x · Cited by 47
Guo, J., Guo, N., Lang, L., Kiesewetter, D. O., Xie, Q., Li, Q., Eden, H. S., Niu, G., & Chen, X. S. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.122069 · Cited by 47
Self-citationMinamimoto, R., Jamali, M., Barkhodari, A., Mosci, C., Mittra, E., Shen, B., Chin, F. T., Gambhir, S. S., & Iagaru, A. H. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3096-4 · Cited by 47
Comparison of Three Dimeric 18F-AlF-NOTA-RGD Tracers
Guo, J., Lang, L., Hu, S., Guo, N., Zhu, L., Sun, Z., Ma, Y., Kiesewetter, D. O., Niu, G., Xie, Q., et al. (2013) · Molecular Imaging and Biology · doi:10.1007/s11307-013-0668-1 · Cited by 46
Self-citationWu, H., Chen, H., Pan, D., et al. (2014) · Molecular Imaging and Biology · doi:10.1007/s11307-014-0761-0 · Cited by 45
Self-citationTomasi, G., Kenny, L. M., Mauri, F. A., Turkheimer, F., & Aboagye, E. O. (2011) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-011-1907-9 · Cited by 41
PET imaging of early response to the tyrosine kinase inhibitor ZD4190
Yang, M., Gao, H., Yan, Y., Sun, X., Chen, K., Quan, Q., Lang, L., Kiesewetter, D. O., Niu, G., & Chen, X. S. (2011) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-011-1742-z · Cited by 37
Self-citationIntegrin Targeted Imaging and Therapy
Chen, X. (2011) · Theranostics · doi:10.7150/thno/v01p0028 · Cited by 37
Self-citationModular strategies for PET imaging agents
Hooker, J. M. (2009) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2009.10.005 · Cited by 36
Shi, J., Jin, Z., Liu, X., Fan, D., Sun, Y., Zhao, H., Zhu, Z., Liu, Z., Jia, B., & Wang, F. (2014) · Molecular Pharmaceutics · doi:10.1021/mp5003202 · Cited by 32
Guo, N., Lang, L., Gao, H., Niu, G., Kiesewetter, D. O., Xie, Q., & Chen, X. S. (2012) · Molecular Imaging and Biology · doi:10.1007/s11307-012-0541-7 · Cited by 31
Self-citationWu, H., Chen, H., Sun, Y., Wan, Y., Wang, F., Jia, B., & Su, X. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.01.053 · Cited by 19
Self-citationQuantitative Evaluation of Tumor Early Response to a Vascular-Disrupting Agent with Dynamic PET
Guo, N., Zhang, F., Zhang, X., Guo, J., Lang, L., Kiesewetter, D. O., Niu, G., Li, Q., & Chen, X. S. (2015) · Molecular Imaging and Biology · doi:10.1007/s11307-015-0854-4 · Cited by 6
Self-citation
Cited by
Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy
Zhou, Z., Song, J., Nie, L., & Chen, X. (2016) · Chemical Society Reviews · doi:10.1039/c6cs00271d · Cited by 2,098
Self-citationThe Current State of Peptide Drug Discovery: Back to the Future?
Henninot, A., Collins, J. C., & Nuss, J. M. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00318 · Cited by 1,113
Xie, J., Bi, Y., Zhang, H., Dong, S., Teng, L., Lee, R. J., & Yang, Z. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00697 · Cited by 466
Exploring the Role of RGD-Recognizing Integrins in Cancer
Nieberler, M., Reuning, U., Reichart, F., Notni, J., Wester, H.-J., Schwaiger, M., Weinmüller, M., Räder, A., Steiger, K., & Kessler, H. (2017) · Cancers · doi:10.3390/cancers9090116 · Cited by 429
Fundamentals and developments in fluorescence-guided cancer surgery
Mieog, J. S. D., Achterberg, F. B., Zlitni, A., Hutteman, M., Burggraaf, J., Swijnenburg, R.-J., Gioux, S., & Vahrmeijer, A. L. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00548-3 · Cited by 389
Metadata
- Authors
- Chen, H., Niu, G., Wu, H., & Chen, X.
- Venue
- Theranostics
- Publisher
- Ivyspring International Publisher
- Published
- 2016
- Volume
- 6
- Issue
- 1
- Pages
- 78-92
- ISSN
- 1838-7640 (ISSN-L)
- OpenAlex
- W2418529341
- Cited by
- 282
- References
- 83
- FWCI
- 18.72
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.